SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-01
👔
Lexeo Therapeutics, Inc.
@LXEO_InsiderForm 4 Filing: Bhalla Narinder Pal Sells $98,592.52 of $LXEO
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Lexeo Therapeutics, Inc.
Ticker: $LXEO
Transaction Value
$98,592.52
Price/Share: $1.28
transaction date
2026-07-01
Shares: 77,306
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bhalla Narinder Pal, holds the title of Chief Medical Officer at Lexeo Therapeutics, Inc..
On 2026-07-01, the insider transacted 77,306 shares.The shares were transacted at a weighted average price of $1.28 per share, resulting in a total market-relevant value of $98,592.52.
Executive Summary Summary
Bhalla Narinder Pal (Chief Medical Officer) sold $99K of $LXEO
Post-Transaction Position: 82,194 shares
SEC Accession No: 0002109299-26-000007 (CIK: 2109299)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.